Original-Research: MLP SE (von NuWays AG): BUY
28.04.2026 - 09:00:55 | dpa.de
Original-Research: MLP SE - from NuWays AG
28.04.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS
Group.
The issuer is solely responsible for the content of this research. The
result of this research does not constitute investment advice or an
invitation to conclude certain stock exchange transactions.
---------------------------------------------------------------------------
Classification of NuWays AG to MLP SE
Company Name: MLP SE
ISIN: DE0006569908
Reason for the research: Update
Recommendation: BUY
Target price: EUR 12
Target price on sight of: 12 months
Last rating change:
Analyst: Simon Keller
Planning pays dividends
We hosted a roadshow with MLP CEO Dr. Uwe Schroeder-Wildberg. Key takeaways
confirm the equity story momentum: MLP combines a c. 5% dividend yield with
continuously improving revenue visibility and tangible adj. earnings growth.
* Client proposition centred on "peace of mind". MLP's model is built
around long-term financial planning and stable, mostly fee-based,
adviser relationships. This is relevant in a market where customers can
easily compare single products such as Tagesgeld, neobank accounts or
ETFs. MLP's focus remains the full financial package: banking,
insurance, wealth, old-age provision and financing, anchored in personal
advice and a long-term customer relationship. This supports retention
and cross-selling as clients move through life stages.
* Earnings quality continues to improve. 72% of sales are already
recurring. Wealth and property and casualty (P&C) insurance are the main
recurring growth pillars, helped by savings plans, rising customer
maturity and inflation-linked premium volumes in non-life insurance.
This improves forecasting quality and lowers reliance on one-off product
sales. Against this backdrop, performance fees are not the foundation:
MLP includes only high-single-digit EURm performance fees annually (c. 1%
of sales) in its mid-term targets, compared to a seven-year average of
c. EUR 23m. With c. 70% incremental EBIT margin, stronger performance fees
would be upside. 2025 also offers a low comparable base (only c. EUR 11m).
* Disintermediation risk looks manageable. Neobanks, ETFs and AI remain
relevant competitive forces, especially on pricing. Still, human advice
remains the single most trusted source of investment guidance (source:
CFA Institute), supporting the relevance of MLP's adviser-led model.
MLP's answer is to integrate digitalisation and AI into the advisory
process, improving transparency, speed and adviser productivity while
preserving the personal relationship.
* AI is turning into an operating lever. MLP already uses AI in
business-relevant processes, with cost control visible in 2025 (adj.
EBIT margin up 0.1pp yoy, despite declining performance fees). In P&C,
an AI-supported claims solution can handle claims in roughly 10 minutes.
Simultaneously, an insurance contract-checking tool can analyse existing
client contracts and generate counter-offers with better pricing, better
service or both. This supports customer benefit, adviser efficiency and
the broader digitalisation case.
* Dividend case backed by growth and cash. The dividend (5% yield at
current levels) remains well supported by MLP's 50-70% payout target and
an expected 14% adj. EBIT CAGR into 2028e (eNuW, in line with mid-term
targets). Consequently, the sustainable dividend should grow going
forward, further anchored by MLP's ambition to maintain dividend
continuity. In addition, EUR >80m net available cash after regulatory
buffers leaves room for M&A, special dividends or buybacks. Yet, the
cash buffer should be seen to maintain financial flexibility, rather
than a near-term distribution trigger.
In sum, MLP remains a quality financial advisory platform with a rare
combination of yield, earnings growth, recurring revenue visibility and
balance-sheet quality. BUY, PT EUR 12, on Residual Income.
You can download the research here:
https://eqs-cockpit.com/c/fncls.ssp?u=58b7818201ec02b3a4cb5b5ab8c50bde
For additional information visit our website:
https://www.nuways-ag.com/research-feed
Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss
bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben
analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++
---------------------------------------------------------------------------
The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
View original content:
https://eqs-news.com/?origin_id=4ac7d2b1-42c9-11f1-8534-027f3c38b923&lang=en
---------------------------------------------------------------------------
2316202 28.04.2026 CET/CEST
So schätzen die Börsenprofis Aktien ein!
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
Für. Immer. Kostenlos.
de | boerse | 69250758 |
